Timely CAR-T Access: Perspectives From Experts

Listen

0:00 / 0:00

In this AJMC® Roundtable discussion, healthcare decision makers examined barriers to timely CAR T-cell therapy access and identified solutions to streamline approval processes and enhance payer education for improved patient care.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Timely CAR-T Access: Perspectives From Experts

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access